|
|
|
40
|
A322JV
|
VENLAFAXINE SR 75MG CAP (APL/AHI) VENLAFAXINE
|
VENLAFAXINE
|
VENLAFAXINE SR
|
1000'S
|
BP
|
516.21
|
0.52
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
A322JY
|
VENLAFAXINE SR 150MG TAB (WAT/AHI) VENLAFAXIN
|
VENLAFAXINE
|
VENLAFAXINE SR
|
90'S
|
BP
|
64.32
|
0.71
|
TABLET
|
0
|
TAB
|
WAT
|
WATSON (ACTAVIS) PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
A322KD
|
LEXAPRO 20MG TAB (LUN/COL) ESCITALOPRAM
|
ESCITALOPRAM
|
LEXAPRO
|
14'S
|
C
|
89.54
|
6.40
|
TABLET
|
0
|
TAB
|
LUN
|
H. LUNDBECK & CO. A/S
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322KE
|
EFFEXOR XR 75MG CAP (PFI/SBI) VENLAFAXINE
|
VENLAFAXINE
|
EFFEXOR XR
|
14'S
|
C
|
67.80
|
4.84
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322KN
|
FLUOXETINE 20MG TAB (APL/AHI)
|
FLUOXETINE
|
FLUOXETINE
|
1000'S
|
A
|
120.97
|
0.12
|
TABLET
|
120
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-09-20
|
2024-03-31
|
Package Size Change
|
oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-09-20
|
|
|
|
40
|
A322KR
|
VENLAFAXINE ER 150MG CAP (APL/AHI) VENLAFAXIN
|
VENLAFAXINE
|
VENLAFAXINE ER
|
90'S
|
BP
|
69.43
|
0.77
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322KS
|
VENLAFAXINE ER 75MG CAP (APL/AHI) VENLAFAXINE
|
VENLAFAXINE
|
VENLAFAXINE ER
|
30'S
|
BP
|
18.97
|
0.63
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322KV
|
EFFEXOR XR 150MG CAP (PFI/SBI) VENLAFAXINE
|
VENLAFAXINE
|
EFFEXOR XR
|
14'S
|
C
|
67.80
|
4.84
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
Price Change
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-04-01
|
|
|
|
40
|
A322KX
|
EFFEXOR XR 150MG CAP (PFI/STO) VENLAFAXINE
|
VENLAFAXINE
|
EFFEXOR XR
|
28'S
|
C
|
135.59
|
4.84
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-07-12
|
2024-03-31
|
Package Size Change
|
Oral
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-07-12
|
|
|
|
41
|
A322KX
|
EFFEXOR XR 150MG XR CAP (PFI) VENLAFAXINE (C)
|
VENLAFAXINE
|
EFFEXOR XR
|
28'S
|
C
|
136.81
|
4.8862
|
CAPXR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
40
|
A322KY
|
EFFEXOR XR 75MG CAP (PFI/STO) VENLAFAXINE
|
VENLAFAXINE
|
EFFEXOR XR
|
28'S
|
C
|
135.59
|
4.84
|
CAPSULE
|
0
|
CAP
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-07-12
|
2024-03-31
|
Package Size Change
|
Oral
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-07-12
|
|
|
|
41
|
A322KY
|
EFFEXOR XR 75MG XR CAP (PFI) VENLAFAXINE (C)
|
VENLAFAXINE
|
EFFEXOR XR
|
28'S
|
C
|
136.81
|
4.8862
|
CAPXR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE
|
|
|
|
|
41
|
A322LA
|
APO-CITALOPRAM 20MG TAB (APO)
|
CITALOPRAM
|
APO-CITALOPRAM
|
30'S
|
A
|
6.93
|
0.2311
|
TAB
|
42
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LB
|
APO-ESCITALOPRAM 10MG TAB (APO) ESC (C)
|
ESCITALOPRAM
|
APO-ESCITALOPRAM
|
100'S
|
C
|
14.98
|
0.1498
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LC
|
APO-FLUOXETINE 20MG TAB (APO)
|
FLUOXETINE
|
APO-FLUOXETINE
|
100'S
|
A
|
7.77
|
0.0777
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LD
|
APO-PAROXETINE 20MG TAB (APO)
|
PAROXETINE
|
APO-PAROXETINE
|
100'S
|
A
|
25.42
|
0.2542
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LE
|
APO-SERTRALINE 50MG CAP (APO) SERTRALINE
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
12.15
|
0.1215
|
CAP
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LF
|
APO-SERTRALINE 100MG CAP (APO)
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
19.41
|
0.1941
|
CAP
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LK
|
APO-ESCITALOPRAM 20MG TAB (APO) (C)
|
ESCITALOPRAM
|
APO-ESCITALOPRAM
|
100'S
|
C
|
29.96
|
0.2996
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LU
|
EFFEXOR 75MG XR CAP (PFI) VENLAFAXINE (C)
|
VENLAFAXINE
|
EFFEXOR
|
28'S
|
C
|
136.81
|
4.8862
|
CAPXR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|